×
Top Dividend Stocks to Buy before the prices go up!
Download Your Free Stock Report!
Our expert team of analysts helps you with Buy, Hold & Sell recommendations!
Our goal is to provide you with best stock market recommendations At the Right Price - At the Right Time
To Get Free Reports Register Now
Register Now
By clicking this button, you agree to our
Terms of Service
and
Privacy Policy
& our Financial Services Guide
(FSG)
×
7 Days Free Trial
Submit
info@aceinvestors.com.au
(02) 9199 9639
Members Login
Contact Us
Home
Research Reports
Daily Recommendations
Dividend Income Report
Growth Stock Report
Speculative Stock Report
US Stock Report
Under 50 cents Special
US Market Report
Segment Specific
Blue Chip
Mid Cap
Small Cap
IPO
Sector Coverage
Banking
Entertainment
Financials
Telecom
Healthcare
Food, Beverage & Tobacco
Insurance
Services and Materials
Technology & IT
IPO
Mining
Energy
Media
Industrial
Utility
Retail
Real Estate
Airlines & Transportation
Consumer Discretionary
Editorial
Sample Report
Subscribe
Healthcare
Home
Healthcare
Alcidion Group Limited (ASX: ALC): Targeting ...
By ACE Investors / 21 Nov 2024
Read More
Bluebird Bio Inc. (NASDAQ: BLUE): Announced a...
By ACE Investors / 20 Nov 2024
Read More
Amgen Inc (NASDAQ: AMGN): Delivered a 22% YoY...
By ACE Investors / 18 Nov 2024
Read More
MedAdvisor Ltd (ASX: MDR): MedAdvisor deliver...
By ACE Investors / 18 Nov 2024
Read More
Jazz Pharmaceuticals plc (NASDAQ: JAZZ): Jazz...
By ACE Investors / 15 Nov 2024
Read More
Centene Corporation (NASDAQ: CNC): Delivered ...
By ACE Investors / 08 Nov 2024
Read More
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE)...
By ACE Investors / 07 Nov 2024
Read More
Enovis Corp. (NYSE: ENOV): An expanded Recon ...
By ACE Investors / 06 Nov 2024
Read More
Trajan Group Holdings Limited (ASX: TRJ): Ach...
By ACE Investors / 05 Nov 2024
Read More
Dimerix Limited (ASX: DXB): Dimerix and Taiba...
By ACE Investors / 04 Nov 2024
Read More
Microba Life Sciences Limited (ASX: MAP): Com...
By ACE Investors / 04 Nov 2024
Read More
Aroa Biosurgery Ltd (ASX: ARX): Focused on in...
By ACE Investors / 01 Nov 2024
Read More
1
2
3
Next >
Last ›
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2024 ACE Investors. All Right Reserved. Design by
Ace Investors